MM&M’S most-read stories of 2017
Topping the list: The MM&M agency issue, the MM&M Awards winners and shortlist, and how a porn star is providing sex ed to seniors
DTC
Five things for pharma marketers to know: Tuesday, August 29, 2017
Drug ads make up to 38% of prime time commercials; Merck considers whether to pursue FDA approval for anacetrapib; BMS and Daiichi partner
Five things for pharma marketers to know: Tuesday, August 8, 2017
A shorter list of risks in TV ads helps consumer comprehension; medical-school choice affects prescribing patterns; reps often show docs the same info
How Do Docs Learn About New Drugs? TV, Of Course
If asked, some will equivocate and say they get their facts from medical journals and from published studies, but never from those pesky misleading ads.
AMA votes to require disclosure of drug prices in DTC ads
The association also recommended that the Centers for Medicare and Medicaid Services negotiate drug prices.
Physicians call for DTC ads to include retail prices
They are asking the American Medical Association to support the policy proposal.
The FDA cites risk info in letter over Contrave DTC ad
The regulator also took issue with how Orexigen Therapeutics presented the risk information
What doctors have to say about those DTC ads
We had SERMO, a social network for physicians, ask about 1,700 physicians what they have to say about the impact of DTC on patient care and choices. Note: It’s not pretty.
The DTC Ads of 2016 That Shouldn’t Have Happened
Pharma marketers are producing plenty of exceptional creative work in the DTC realm. There are also plenty that prompt quick checks to make sure that one hasn’t inadvertently clicked over to The Onion.
The Top 10 DTC Ads of 2016
Mary Skoyles finds that DTC ads are getting better. “There’s a lot of interesting work being done,” she says. “There are more chances being taken.”
